Cell debris was removed from culture
supernatant by centrifugation at 12,500 g for 45 min at 4 °C, and the virus particles were concentrated by ultracentrifugation at 45,000 r.p.m in a BECKMAN 70Ti rotor for 3 hrs.
Not exact matches
Hybridoma
supernatants were screened for anti-rGRF activity
by use of a pituitary culture assay system that can detect growth hormone - releasing factor in the femtomole range.
By securing a pellet (with neodymium magnets) on the sides of the tube walls rather than at the bottom, it allows complete removal of the
supernatant without touching the pellet.
To confirm the generation of infectious virus, viral
supernatants were quantitated
by an end - point dilution assay.
After the third wash, the
supernatant was discarded down to 100 µl and 650 µl of Tris - HCL buffer was added followed
by 250 µl of fresh / frozen reduction buffer (100 mM Tris - Cl pH 7.4, 40 mM DTT).
Angiopoietin - 2 protein levels of cell culture
supernatants were measured
by ELISA (R&D, #DANG20) according to the manufacturer's instructions.
Homogenates were cleared
by centrifugation at 100.000 g for 1 h at 4 °C, and
supernatants were collected for further analysis (TBS - soluble fraction).
Five hours later, the
supernatants were collected to determine cytokine levels
by ProcartaPlex Multiplex Immunoassays.
Cell
supernatants were separated
by SDS - PAGE on a 4 — 15 % gradient gel (Bio-Rad; Hercules, CA).
Cell
supernatants were analyzed for IL - 22 production
by ELISA.
Cell lysates were analyzed for RNA and
supernatants were analyzed for secreted IL - 22
by ELISA.
Cell
supernatants were analyzed for IL - 22 secretion
by ELISA.
Because ATRA could cause IFNα synthesis and secretion in NB4 cells
by up - regulating IRF - 1 (23), we thus quantitated the IFNα in culture
supernatant of ATRA - treated NB4 cells.
Flow cytometric analysis of BT474, MCF7 / HER2, or MCF7 target cells after incubation with
supernatant from HB1.F3.H2IgG, HB1.F3.Adeno - H2IgG, or HB1.F3.Lenti - H2IgG (C), followed
by incubation with FITC - conjugated anti-human IgG (blue histograms).
After 2 days, the viral
supernatant was collected
by spinning and passing through a Millex - HV 0.45 um filter unit (Millipore).
Cells were incubated with GCTM2 hybridoma
supernatant (mouse IgM) for 30 min at room temperature following
by three washes with 100 mM Tris - HCl, pH 8.5.
Single - cell suspension was obtained
by filtering the
supernatant through a 40 - μm cell strainer, and cell suspension was then gently loaded onto a layer of Histopaque - 1077 gradient (1 × 106 — 3 × 106 cells / mL HistoPaque in a total of 3 - mL volume) and then centrifuged at 400 × g for 30 min at room temperature.
Afterwards, the
supernatant was removed
by a short spin of the plate bottom up at no more than 9 × g. To wash the pellet, 50 µl of 70 % ethanol was pipetted into each well and again the plate was spun bottom up at no more than 9 × g for 5 — 10 sec.
Immunoglobulin - containing HB1.F3.H2IgG NSC culture
supernatant was subjected to purification
by protein A affinity chromatography.
The
supernatant was mixed with 300 µl of Ni - NTA agarose (Qiagen), and the proteins were allowed to bind for 3 hours, followed
by washing with 20 ml of resuspension buffer, and eluted with 500 µl of elution buffer (20 mM NaHPO4, 300 mM NaCl, 10 % glycerol, 150 mM Imidazole, pH 7.8).
These changes were accompanied
by severe EC damage, decreased E-cadherin RNA level, elevated IFN - gamma in splenocyte culture
supernatant, and production of significant IgM antibody against intestinal microbiota.
Combined culture
supernatant and deoxycholate reduced calcium uptake
by 39 % (p less than 0.001) suggesting a potentiation of
supernatant activity
by deoxycholate.
«The
supernatant decreased the in vitro uptake of calcium
by 15 % (p less than 0.001).